Introduction
============

Telocytes (TCs) were first described as a distinct cell type in 2010 [@b1],[@b2], followed by a significant growing of research globally [@b3],[@b4], as detailed in [www.telocytes.com](http://www.telocytes.com). TCs were found in multiple tissues and organs, such as heart [@b5]--[@b7], kidney [@b8] and urinary tract [@b9],[@b10], skin [@b11],[@b12] eye [@b13], mammary gland [@b14], digestive tract [@b15],[@b16], skeletal muscles [@b17] and neuromuscular spindles [@b18], uterus [@b19]--[@b22] and placenta [@b2], liver [@b23] and gall bladder [@b24],[@b25], pleura [@b26], trachea [@b27] and lungs [@b28]. TCs are mainly recognized and characterized by electron microscopy, the only technique able to highlight their characteristic extensions -- the telopodes (Tps), consisting of thin segments -- podomers, alternating with dilated regions -- podoms [@b1]. Other characteristics of Tps include: (*i*) the unusual and varied length, between tens and thousands of micrometres; (*ii*) the branching network pattern, forming a labyrinthine system; (*iii*) the communications through homo-and heterocellular junctions exosome and ectosome release [@b6],[@b20],[@b22]. TCs were found to link nerve fibres, blood vessels, secretory acini and exocrine epithelial ducts [@b29]--[@b31], and different cell types, *e.g*. macrophages, lymphocytes, mast cells, stem cells [@b32]--[@b34]. TCs form 3-dimensional networks within organs/tissues [@b20],[@b35]. Networks integrity may be affected in many pathological conditions, such as systemic sclerosis [@b36], skin basal and squamous cell carcinomas [@b37] and Crohn\'s disease [@b38].

Telocytes differ from fibroblasts (Fbs) and mesenchymal stem cells (MSCs) as demonstrated by miR signatures and genetic profiles [@b15],[@b39],[@b40]. Proteomic signatures of the TCs are also supportive for the uniqueness and helpful in understanding of the functions. The data from omics studies demonstrated that elements within TCs are involved in (*i*) intercellular signalling, (*ii*) mechanical sensing and mechanochemical conversion task, (*iii*) tissue homoeostasis and remodelling/renewal, (*iv*) anti-oxidative stress and anti-ageing cellular mechanisms, (*v*) cancer cell proliferation through the inhibition of apoptosis [@b40],[@b41]. Our recent work explored patterns of mouse TC-specific gene profiles on chromosome 1 and showed important roles for TCs in the prevention of tissue inflammation and fibrogenesis, development of lung inflammatory diseases or modulation of immune cell responses [@b42]. However, dominant patterns and specificity of gene and protein profiles of TCs which are different from other cells existed in the lung is still not completed and unclear.

The present study undertakes an in-depth analysis to find out the characters and patterns of TC-specific or TC-dominated gene expression profiles in chromosome 2 and 3, investigate the network of principle genes, and explore potential functional association. Comparisons are made among pulmonary TCs, MSCs, Fbs, alveolar type II cells (ATII), airway basal cells (ABCs), proximal airway cells (PACs), CD8^+^T cells from bronchial lymph nodes (T-BL) and CD8^+^ T cells from lung (T-L), which may interact with TCs in the lung and trachea. Furthermore, we applied the most complete reference library of the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus database to identify key functional genes, and characteristic networks by bioinformatics tools.

Material and methods
====================

Isolation and culture
---------------------

Telocytes were isolated from the lung tissues of mice, primary cultured in a concentration of 1 × 10^5^ cells/cm^2^, and harvested on days 5 (TC D5) and on days 10 (TC D10), as described previously [@b43]. RNA isolation, preparation, labelling, and hybridization were performed for DNA microarray (The Mouse 4 × 44K Gene Expression Array, Agilent, Shanghai, China). About 39,000+ mouse genes and transcripts represented with public domain annotations were gained, according to the protocol of One-Color Microarray-Based Gene Expression Analysis. The hybridized arrays were washed, fixed and scanned by the Agilent DNA Microarray Scanner (part number G2505B).

Data collection and mining
--------------------------

We selectively collected gene expression profiles of pulmonary TCs on days 5 (TC D5) and 10 (TC D10), Fbs, MSCs, from our study [@b43], ATII, ABCs, PACs, T-BL and T-L, from the NCBI Gene Expression Omnibus database (GSE6846 [@b44], GSE27379 [@b45], GSE28651 [@b46]). The microarray was composed of 45,101 probes. We eliminated the probe sets without corresponding official symbol, leaving 39,417 probes and 21,680 genes.

The gene expression profiles are from our earlier study, which are composed of 23,861 probes, of pulmonary TCs on days 5 and 10, Fbs and MSCs are composed of 23,861 probes [@b43]. There were 13,236 probes and 11,545 genes after further eliminating the probes without corresponding official symbol, which we focused on in the present study. From the total of 11,545 genes, 917 genes of the chromosome 2 and 567 genes of the chromosome 3 were analysed.

Identification of differentially expressed genes
------------------------------------------------

There are about 20,000--25,000 genes in mouse, of which about 85% are similar with humans, and the propensity of functional changes was reflected in different levels of the gene expression in particular cell types. We used gene expression profiles between mouse lung cells to seek for the specific regulated and identify genes specific to TCs and their function. The fold change was utilized to identify differentially expressed genes or simply differential genes. Up-or down-regulated folds of TCs genes were calculated as compared with other cells and subtracted its own multiple of TCs, after the average of gene expression in each cell was obtained from the raw data of multi-databases, as shown in Data S1.

Results
=======

The final data analysis by bioinformatics tools showed that in chromosome 2*,* 26 genes were overexpressed in TCs, as compared with those in other cells (Table[1](#tbl1){ref-type="table"}). Among them, 20 genes (1110008F13Rik, 2310003F16Rik, 2900064A13Rik, Abl1, Ass1, Commd3, Commd7, Creb3l1, Dlgap4, Edf1, Id1, Manbal, Mocs3, Psmc3, Sdccag3, Slc39a13, Snai1, Spc25, Tubb2c, Srxn1) were overexpressed between 0 and 1 folds (Table[1](#tbl1){ref-type="table"}A). Four genes, Dbndd2 (Dysbindin domain-containing protein 2), Fbn1 (fibrillin 1), Tfpi (tissue factor pathway inhibitor) and Ak1 (adenylate kinase 1) genes, were overexpressed one-to-fourfold, in both TC D5 and TC D10, as compared with other cells (Table[1](#tbl1){ref-type="table"}B). Highest overexpressed gene, Myl9 (myosin, light chain 9), was over fourfold up-regulated in both TC D5 and TC D10 compared with other cells (Table[1](#tbl1){ref-type="table"}C). 80 genes in TCs were down-regulated, as compared with other cells (Table[2](#tbl2){ref-type="table"}). Of them, Gzf1, Pltp, Polr1b, Tasp1, Zbtb34 and Zfp120 were down-regulated more than onefold in TCs compared with other cells.

###### 

Summary of genes expressed preferentially in TCs, as compared with others

  Compared pairs/fold up-regulated                                                \>0                                                \>1           \>4                                                     
  ------------------------------------------------------------------------------- -------------------------------------------------- ------------- ------------- ------------- ------------- ------------- -------------
  TC5 *versus* others                                                             64                                                 18            2                                                       
  TC10 *versus* others                                                            56                                                 13            4                                                       
  TCs *versus* others                                                             26                                                 6             2                                                       
  Gene symbol                                                                     Folds (TC5 *versus* others/TC10 *versus* others)                                                                         
  Fibroblast                                                                      Stem                                               ATII          CD8_T\_BL     CD8_T\_LL     Basal_cell    Duct_cell     
  \(A\) Genes up-regulated between 0-and 1-folds in TCs as compared with others                                                                                                                            
   1110008F13Rik                                                                  −0.41/−0.18                                        −0.46/−0.25   −0.73/−0.72   −0.79/−0.80   −0.85/−0.85   −0.91/−0.91   −0.91/−0.92
   2310003F16Rik                                                                  −0.40/−0.04                                        −0.49/−0.19   −0.97/−0.97   −0.52/−0.46   −0.56/−0.50   −0.82/−0.80   −0.86/−0.84
   2900064A13Rik                                                                  −0.13/−0.21                                        −0.41/−0.46   −0.37/−0.58   −0.29/−0.54   −0.30/−0.54   −0.24/−0.51   −0.19/−0.47
   Abl1                                                                           −0.75/−0.67                                        −0.43/−0.23   −0.76/−0.76   −0.29/−0.32   −0.70/−0.71   −0.82/−0.83   −0.89/−0.90
   Ass1                                                                           −0.44/−0.34                                        −0.96/−0.95   −0.82/−0.84   −0.94/−0.95   −0.80/−0.83   −0.90/−0.92   −0.80/−0.84
   Commd3                                                                         −0.63/−0.13                                        −0.63/−0.54   −0.56/−0.62   −0.78/−0.59   −0.76/−0.60   −0.13/−0.34   −0.24/−0.65
   Commd7                                                                         −0.29/−0.56                                        −0.62/−0.91   −0.58/−0.49   −0.53/−0.99   −0.54/−0.99   −0.24/−0.87   −0.60/−0.89
   Creb3l1                                                                        −0.65/−0.66                                        −0.93/−0.44   −0.46/−0.35   −0.99/−0.18   −0.99/−0.52   −0.86/−0.25   −0.88/−0.29
   Dlgap4                                                                         −0.79/−0.98                                        −0.65/−0.96   −0.44/−0.77   −0.28/−1.00   −0.58/−0.96   −0.34/−0.37   −0.38/−0.71
   Edf1                                                                           −0.44/−0.17                                        −0.40/−0.08   −0.51/−0.73   −0.78/−0.76   −0.81/−0.61   −0.26/−0.28   −0.26/−0.66
   Id1                                                                            −0.98/−0.70                                        −0.97/−0.03   −0.74/−0.20   −0.99/−0.50   −0.95/−0.45   −0.27/−0.63   −0.66/−0.59
   Manbal                                                                         −0.49/−0.51                                        −0.43/−0.43   −0.77/−0.34   −0.79/−0.19   −0.66/−0.19   −0.37/−0.20   −0.71/−0.25
   Mocs3                                                                          −0.81/−0.53                                        −0.38/−0.02   −0.30/−0.90   −0.55/−0.95   −0.51/−0.95   −0.67/−0.55   −0.63/−0.57
   Psmc3                                                                          −0.64/−0.46                                        −0.58/−0.20   −0.34/−0.29   −0.17/−0.58   −0.18/−0.36   −0.18/−0.67   −0.23/−0.93
   Sdccag3                                                                        −0.44/−0.46                                        −0.48/−0.60   −0.76/−0.37   −0.77/−0.98   −0.74/−0.94   −0.73/−0.45   −0.67/−0.18
   Slc39a13                                                                       −0.51/−0.59                                        −0.28/−0.77   −0.13/−0.42   −0.46/−0.73   −0.20/−0.75   −0.58/−0.72   −0.91/−0.80
   Snai1                                                                          −0.84/−0.26                                        −0.37/−0.15   −0.92/−0.67   −0.93/−0.74   −0.95/−0.58   −0.95/−0.40   −0.97/−0.59
   Spc25                                                                          −0.41/−0.37                                        −0.24/−0.40   −0.79/−0.91   −0.61/−0.91   −0.41/−0.91   −0.19/−0.58   −0.07/−0.85
   Tubb2c                                                                         −0.73/−0.59                                        −0.84/−0.48   −0.47/−0.40   −0.74/−0.90   −0.77/−0.89   −0.73/−0.57   −0.81/−0.74
   Srxn1                                                                          −0.49/−0.68                                        −0.71/−0.30   −0.32/−0.86   −0.96/−0.85   −0.93/−0.83   −0.69/−0.86   −0.41/−0.93
  \(B\) Genes up-regulated between 1-and 4-folds in TCs as compared with other                                                                                                                             
   Dbndd2                                                                         −0.61/−1.00                                        −0.66/−0.98   −0.90/−0.73   −0.96/−0.96   −0.95/−0.96   −0.83/−0.87   −0.81/−0.90
   Fbn1                                                                           −0.95/−0.98                                        −0.84/−0.53   −0.89/−0.84   −0.95/−0.82   −0.95/−0.84   −0.66/−0.87   −0.89/−0.76
   Tfpi                                                                           −0.60/−0.72                                        −0.94/−0.58   −0.85/−0.85   −0.66/−0.95   −0.73/−0.96   −0.84/−0.78   −0.82/−0.86
   Ak1                                                                            −0.80/−0.74                                        −0.84/−0.96   −0.69/−0.93   −1.00/−0.85   −0.97/−0.87   −0.94/−0.93   −0.97/−0.92
  \(C\) Genes up-regulated between \>4-folds in TCs as compared with others                                                                                                                                
   Myl9                                                                           −1.00/−0.96                                        −0.92/−0.91   −0.98/−0.92   −1.00/−0.96   −1.00/−0.98   −0.98/−0.88   −1.00/−0.94

###### 

Summary of genes expressed preferentially in TCs, as compared with others

  Compared pairs/fold down-regulated                                                \>0                                                \>1          \>4                                                      
  --------------------------------------------------------------------------------- -------------------------------------------------- ------------ ------------- ------------- ------------- -------------- --------------
  TC5 *versus* others                                                               140                                                14           0                                                        
  TC10 *versus* others                                                              236                                                38           0                                                        
  TCs *versus* others                                                               80                                                 6            0                                                        
  Gene symbol                                                                       Folds (TC5 *versus* others/TC10 *versus* others)                                                                         
  Fibroblast                                                                        Stem                                               ATII         CD8_T\_BL     CD8_T\_LL     Basal_cell    Duct_cell      
  \(A\) Genes down-regulated between 0-and 1-folds in TCs as compared with others                                                                                                                            
   1500012F01Rik                                                                    1.00/2.24                                          2.51/4.68    0.09/0.29     0.83/1.11     1.30/1.68     2.50/3.01      4.17/4.95
   1600027N09Rik                                                                    0.02/0.26                                          0.24/0.53    3.26/2.85     5.59/4.77     6.52/5.68     6.23/5.32      6.80/5.85
   1700058C13Rik                                                                    0.01/0.29                                          0.03/0.31    6.00/5.54     6.63/5.93     15.2/13.91    7.23/6.46      4.82/4.30
   2010317E24Rik                                                                    0.71/2.34                                          1.58/4.04    0.03/0.47     0.23/0.70     1.38/2.34     10.45/14.81    10.14/14.46
   2810408M09Rik                                                                    1.13/1.13                                          0.66/0.66    20.58/14.77   1.23/0.58     14.91/10.44   65.85/46.34    29.46/20.69
   4921504E06Rik                                                                    0.16/0.37                                          0.31/0.55    6.25/5.27     0.87/0.57     8.86/7.40     11.6/9.56      9.10/7.51
   6820408C15Rik                                                                    0.02/0.06                                          0.54/0.61    99.87/75.87   8.76/6.22     28.01/20.77   26.11/19.03    17.2/12.51
   Abca2                                                                            0.77/1.04                                          0.51/0.73    11.84/9.81    5.21/4.07     6.05/4.84     8.82/7.01      6.99/5.55
   Acvr2a                                                                           1.31/1.33                                          0.42/0.43    23.28/16.86   13.98/9.7     25.29/18.05   84.04/59.65    70.93/50.56
   Angptl2                                                                          0.52/0.45                                          1.97/0.31    16.78/0.65    9.96/1.22     5.33/2.03     14.94/3.34     20.00/1.38
   Api5                                                                             0.06/0.28                                          0.40/1.50    3.39/9.94     6.09/5.56     4.92/2.84     3.10/8.51      3.11/11.60
   Arhgap1                                                                          0.30/0.39                                          0.05/0.84    1.45/3.21     1.27/5.61     0.44/4.59     4.67/2.81      3.64/2.84
   Arpc5l                                                                           1.84/1.17                                          0.11/0.75    1.81/1.99     9.73/1.70     7.56/0.73     9.55/5.73      5.43/4.53
   Atf2                                                                             0.15/2.57                                          0.26/0.39    2.39/1.58     7.92/8.55     3.92/6.73     8.87/8.38      5.91/4.74
   B2m                                                                              1.13/0.44                                          0.57/1.06    2.50/1.63     4.18/3.06     4.50/2.19     2.32/1.70      1.22/1.32
   Catsper2                                                                         1.51/0.83                                          0.31/1.01    14.79/2.94    24.41/9.06    27.92/4.63    19.7/10.11     15.59/6.82
   Cbfa2t2                                                                          0.21/0.82                                          0.43/0.34    0.27/1.18     0.97/2.13     0.86/2.37     0.60/1.00      0.28/0.35
   Cdca7                                                                            1.89/1.49                                          6.28/0.30    1.05/10.46    1.2/16.91     0.10/19.66    2.18/13.55     2.49/10.73
   Cep110                                                                           1.61/0.62                                          0.28/0.92    0.84/0.24     7.14/0.87     4.90/0.79     5.53/0.51      2.91/0.22
   Chchd5                                                                           0.45/3.93                                          0.13/11.43   6.34/1.55     3.16/1.67     2.13/0.35     12.54/2.84     10.66/3.24
   Ciz1                                                                             0.30/2.69                                          0.21/0.81    1.53/0.90     0.84/7.16     0.68/4.99     7.8/5.53       4.74/2.93
   Cry2                                                                             0.11/1.18                                          0.15/0.69    13.7/7.05     4.83/3.43     2.42/2.38     10.9/13.38     11.47/11.46
   Ddx27                                                                            0.42/0.74                                          0.44/0.62    0.20/1.47     1.27/0.74     1.09/0.61     5.47/7.32      6.52/4.46
   Ddx31                                                                            0.31/0.36                                          0.93/0.91    0.51/2.65     1.79/8.07     0.75/9.21     5.42/17.28     5.09/13.41
   Depdc7                                                                           1.34/0.33                                          0.42/0.38    13.2/11.89    0.67/3.96     2.85/1.96     2.96/9.11      33.03/9.65
   Dsn1                                                                             0.61/0.26                                          1.33/0.31    6.39/6.62     39.29/12.48   47.16/10.54   12.99/6.54     23.88/5.26
   Elp4                                                                             0.76/1.09                                          0.25/1.12    5.62/0.30     1.29/1.37     1.03/1.21     14.19/5.74     10.08/6.88
   Ext2                                                                             0.44/0.46                                          0.68/1.16    23.82/0.23    31.23/1.21    21.21/0.41    20.92/4.07     11.20/3.83
   Fmnl2                                                                            0.18/1.37                                          0.15/0.44    11.91/9.50    5.60/0.20     12.75/1.80    15.11/1.84     21.28/23.52
   Fubp3                                                                            0.04/0.99                                          0.42/1.88    14.72/5.69    34.28/34.4    32.79/41.90   93.41/11.27    73.83/20.93
   Gapvd1                                                                           0.04/0.18                                          0.09/3.47    3.56/5.04     5.04/13.37    3.84/8.91     3.82/4.01      3.24/2.43
   Gmeb2                                                                            0.30/1.39                                          0.70/0.70    15.73/5.58    17.11/1.21    7.65/0.98     2.14/13.63     2.63/9.73
   Hat1                                                                             0.56/0.99                                          0.09/1.32    12.93/24.06   49.03/30.61   46.29/21.08   26.19/20.45    29.7/11.00
   Il15ra                                                                           1.42/0.59                                          0.07/0.54    2.25/11.67    0.64/5.29     2.21/12.29    4.80/14.33     1.58/20.32
   Mapkbp1                                                                          0.03/0.18                                          0.13/2.25    96.09/4.23    25.15/33.87   22.48/30.68   123.55/25.01   263.85/15.93
   Mga                                                                              0.68/0.24                                          0.34/0.68    4.24/12.63    4.57/28.72    5.14/27.86    8.89/78.35     7.84/62.23
   Mkks                                                                             0.26/0.64                                          0.25/0.71    1.66/4.26     3.04/5.77     2.84/4.51     6.40/4.39      6.51/3.77
   Mllt10                                                                           0.11/1.18                                          0.06/0.54    5.21/2.72     32.27/10.63   27.76/16.87   15.03/12.57    12.67/9.62
   Mrps5                                                                            0.30/0.37                                          0.29/0.79    2.85/11.87    3.12/12.53    1.15/5.55     16.43/1.34     8.73/1.72
   Necab3                                                                           3.74/0.72                                          0.49/0.20    3.72/10.21    2.23/38.12    6.28/36.48    11.85/20.21    3.01/23.07
   Nr6a1                                                                            0.87/2.71                                          0.40/0.63    18.84/2.64    14.87/0.78    18.42/2.54    41.84/5.30     67.71/1.82
   Ntng2                                                                            0.19/0.21                                          0.25/0.33    0.4/82.62     10.52/20.87   12.47/18.91   4.3/102.97     1.66/221.24
   Nusap1                                                                           0.59/1.31                                          1.62/0.83    0.56/4.26     0.21/4.42     0.4/5.07      2.96/8.61      4.62/7.64
   Olfr73                                                                           0.10/0.04                                          0.27/0.02    1.12/0.60     4.73/1.36     1.03/1.28     20.44/3.31     5.83/3.40
   P2rx3                                                                            0.88/0.59                                          0.47/0.52    0.77/5.49     5.71/32.77    1.29/28.59    5.36/15.24     12.31/12.91
   Pdhx                                                                             1.09/0.82                                          0.10/0.80    11.01/2.93    7.06/3.08     5.76/1.16     5.97/16.23     6.61/8.67
   Phf20                                                                            0.77/3.35                                          0.87/0.37    0.88/2.17     5.00/1.11     3.20/3.81     1.03/7.36      0.67/1.62
   Polr3f                                                                           0.83/1.25                                          0.21/0.69    10.77/16.44   10.86/12.56   14.35/15.82   15.73/35.52    7.5/57.87
   Rae1                                                                             0.71/0.82                                          0.58/0.91    0.59/0.56     1.34/11.47    1.61/13.79    4.08/4.73      1.55/1.89
   Rbm38                                                                            1.52/0.58                                          0.11/0.70    18.93/2.24    5.43/1.14     12.22/1.26    10.19/9.83     8.49/7.36
   Scn1a                                                                            9.47/0.74                                          2.38/0.87    0.73/1.13     0.61/3.84     2.46/3.60     7.56/0.30      4.58/0.57
   Slc12a5                                                                          4.24/0.92                                          0.59/2.15    2.84/0.38     3.26/0.04     3.41/0.21     4.93/2.38      5.08/3.83
   Slc27a4                                                                          1.12/0.22                                          0.50/0.41    28.79/0.72    13.26/3.52    6.48/0.62     6.51/15.87     6.71/4.40
   Slc34a3                                                                          0.33/1.15                                          0.38/0.69    10.17/0.48    10.98/4.46    19.71/0.89    20.08/4.17     17.79/9.87
   Spata2                                                                           0.54/1.15                                          0.59/0.13    0.65/8.00     1.75/4.87     0.78/3.99     4.44/4.06      3.95/4.56
   Sptlc3                                                                           0.42/0.74                                          0.31/1.10    26.19/5.08    2.31/7.18     13.32/8.05    179.36/10.23   250.13/8.40
   Ss18l1                                                                           0.33/1.71                                          1.15/1.85    24.07/1.10    70.3/5.51     106.73/3.61   142.18/1.19    87.02/0.81
   Surf6                                                                            0.14/2.78                                          0.03/0.71    0.36/0.10     1.56/1.44     0.98/0.59     4.86/3.33      5.65/2.12
   Timm10                                                                           1.11/0.80                                          0.16/0.19    0.79/7.50     0.44/7.32     0.44/9.91     3.52/10.71     2.82/4.98
   Trub2                                                                            0.41/1.52                                          0.58/1.33    0.34/0.72     1.71/1.45     0.55/1.77     4.38/4.31      1.61/1.68
   Ttll9                                                                            0.06/2.02                                          0.03/0.34    13.59/16.46   4.75/4.47     8.44/10.41    63.39/8.51     39.11/7.1
   Yme1l1                                                                           1.17/14.07                                         0.17/3.87    4.23/0.82     10.71/0.64    12.14/2.59    21.28/7.73     18.6/4.72
   Arl6ip6                                                                          0.33/5.28                                          0.27/0.91    0.09/2.37     1.77/2.62     1.30/2.81     3.37/4.03      2.27/4.19
   Cep152                                                                           0.58/2.53                                          1.26/5.71    1.95/0.32     28.84/1.17    18.63/0.56    5.03/3.14      2.63/3.27
   Chd6                                                                             0.54/0.90                                          1.20/0.97    11.69/10.67   70.65/11.16   61.55/20.31   58.35/20.35    34.4/18.12
   Ddb2                                                                             3.10/1.00                                          0.72/1.06    10.74/0.56    81.94/1.53    91.16/0.66    88.59/3.99     61.48/3.57
   Dnmt3b                                                                           1.85/0.69                                          0.05/0.56    1.45/22.66    16.44/1.80    14.99/11.27   3.61/151.12    1.68/211.91
   Dut                                                                              0.04/2.30                                          0.36/0.50    0.80/1.54     2.32/5.41     1.35/3.55     14.44/1.97     9.05/1.33
   Emilin3                                                                          0.83/0.44                                          0.86/0.29    26.92/0.25    42.07/1.28    59.95/0.79    7.44/4.22      12.92/4.95
   Entpd6                                                                           1.61/1.68                                          0.30/0.48    41.36/0.66    38.04/0.30    17.21/0.32    17.79/3.07     12.23/2.46
   Mettl5                                                                           0.61/0.10                                          0.37/0.06    2.72/10.00    6.88/3.21     4.9/6.00      6.01/46.04     5.83/28.46
   Myef2                                                                            0.58/0.69                                          0.11/0.33    0.74/1.38     0.91/3.04     2.12/3.57     4.87/9.78      3.94/8.22
   Rif1                                                                             0.94/1.19                                          1.76/3.64    0.98/14.02    5.85/10.48    7.01/7.97     3.27/6.11      2.11/0.65
   Sfmbt2                                                                           2.56/2.25                                          3.80/1.98    1.09/1.49     7.35/0.88     9.00/1.40     2.16/7.25      0.94/5.39
  \(B\) Genes down-regulated between 1-and 4-folds in TCs as compared with others                                                                                                                            
   Gzf1                                                                             1/3.12                                             3.24/1.05    17.78/47.88   13.78/42.76   10.39/19.69   8.17/20.02     1.12/13.88
   Pltp                                                                             9.94/3.83                                          2.17/3.01    189.9/16.60   7.67/31.99    8.30/21.33    110.19/13.79   96.66/22.44
   Polr1b                                                                           1.83/1.59                                          1.33/1.47    7.01/5.03     6.45/10.25    3.06/18.41    10.71/37.36    8.50/46.25
   Tasp1                                                                            2.19/7.78                                          1.12/8.13    1.96/2.59     15.91/2.34    12.47/4.49    20.97/8.59     8.31/9.50
   Zbtb34                                                                           2.82/4.42                                          1.78/2.60    58.06/2.67    131.6/19.40   78.44/15.48   69.44/25.45    58.72/10.27
   Zfp120                                                                           1.92/1.70                                          1.84/1.62    17.79/11.67   21.29/13.60   18.08/11.68   11.75/7.33     8.68/5.36

A set of genes are specifically up-or down-regulated in pulmonary TCs, as compared with other cells in chromosome 2 (Table[3](#tbl3){ref-type="table"}), up-or down-regulated genes more than 0-fold of TCs D5 were 576 or 341, 559 or 358, 228 or 689, 287 or 630, 277 or 640, 181 or 736, or 210 or 707, respectively, as compared with MSCs, Fbs, ATII, T-BL, T-L, ABCs, or PACs. Up-or down-regulated genes more than 0-fold of TCs D10 were 431 or 486, 408 or 509, 238 or 679, 294 or 623, 288 or 629, 182 or 735, or 222 or 695, as compared with MSCs, Fbs, ATII, T-BL, T-L, ABCs or PACs respectively. Up-and down-regulated genes more than 0-fold of TCs were 406 or 316, 388 or 338, 204 or 655, 262 or 598, 251 or 603, 158 or 712, or 180 or 665, as compared with MSCs, Fbs, ATII, T-BL, T-L, ABCs or PACs respectively.

###### 

The number of genes specifically up-or down-regulated in pulmonary telocytes, as compared with other cells respectively

  Compared pairs             Up\>0   Up\>1   Up\>4   Down\>0   Down\>1   Down\>4
  -------------------------- ------- ------- ------- --------- --------- ---------
  TC5 *versus* stem          576     194     50      341       80        14
  TC10 *versus* stem         431     136     41      486       152       27
  TCs *versus* stem          406     116     30      316       73        14
  TC5 *versus* fibroblast    559     201     79      358       107       17
  TC10 *versus* fibroblast   408     166     61      509       178       33
  TCs *versus* fibroblast    388     140     56      338       93        14
  TC5 *versus* ATII          228     102     36      689       504       289
  TC10 *versus* ATII         238     104     35      679       516       296
  TCs *versus* ATII          204     86      30      655       476       268
  TC5 *versus* CD8BL         287     174     89      630       689       303
  TC10 *versus* CD8BL        294     196     97      623       485       284
  TCs *versus* CD8BL         262     160     81      598       461       262
  TC5 *versus* CD8LL         277     178     92      640       487       306
  TC10 *versus* CD8LL        288     187     97      629       482       289
  TCs *versus* CD8LL         251     162     84      603       458       263
  TC5 *versus* basal cell    181     89      42      736       612       414
  TC10 *versus* basal cell   182     101     41      735       601       406
  TCs *versus* basal cell    158     79      36      712       573       375
  TC5 *versus* duct cell     210     118     50      707       552       358
  TC10 *versus* duct cell    222     117     51      695       548       345
  TCs *versus* duct cell     180     103     42      665       522       320

In chromosome 3, 13 genes were higher than 0-fold in TCs, as compared with those in other cells (Table[4](#tbl4){ref-type="table"}), of which 10 genes (Agl, Ecm1, Golim4, Kcnab1, Lce1a2, Nexn, Pde4dip, Plekho1, Psrc1, Rhoc, Rit1, Scamp3, Sec22b) were overexpressed 0-to 1-fold (Table[4](#tbl4){ref-type="table"}A). Three genes Sh3glb1 (SH3-domain GRB2-like B1 -- endophilin), Tm4sf1 (transmembrane 4 superfamily member 1) and Csf1 (colony stimulating factor 1) were overexpressed more than onefold, in both TC D5 and TC D10, as compared with other cells (Table[4](#tbl4){ref-type="table"}B). 59 genes in TCs were down-regulated, as compared with other cells (Table[5](#tbl5){ref-type="table"}). Of them, 1700013F07Rik, Amy1, Anp32e, Dnase2b, Fmo5, Pde5a, Phf17, Rwdd3 and Trim33 were down-regulated more than onefold, in both TC D5 and TC D10, as compared with other cells.

###### 

Summary of genes expressed preferentially in TCs, as compared with others

  Compared pairs/fold up-regulated                                                \>0                                                \>1           \>4                                                      
  ------------------------------------------------------------------------------- -------------------------------------------------- ------------- ------------- ------------- ------------- -------------- -------------
  TC5 *versus* others                                                             42                                                 10            0                                                        
  TC10 *versus* others                                                            30                                                 7             2                                                        
  TCs *versus* others                                                             13                                                 3             0                                                        
  Gene symbol                                                                     Folds (TC5 *versus* others/TC10 *versus* others)                                                                          
  Fibroblast                                                                      Stem                                               ATII          CD8_T\_BL     CD8_T\_LL     Basal_cell    Duct_cell      
  \(A\) Genes up-regulated between 0-and 1-folds in TCs as compared with others                                                                                                                             
   Agl                                                                            −0.31/−0.25                                        −0.42/−0.37   −0.64/−0.6    −0.54/−0.5    −0.81/−0.79   −0.63/−0.6     −0.79/−0.77
   Ecm1                                                                           −0.96/−0.96                                        −0.9/−0.9     −0.91/−0.91   −0.96/−0.96   −0.85/−0.85   −0.48/−0.47    −0.24/−0.23
   Golim4                                                                         −0.65/−0.63                                        −0.24/−0.2    −0.86/−0.85   −0.8/−0.79    −0.86/−0.86   −0.65/−0.63    −0.48/−0.45
   Kcnab1                                                                         −0.94/−0.95                                        −0.39/−0.54   −0.73/−0.8    −0.62/−0.71   −0.9/−0.93    −0.24/−0.42    −0.65/−0.73
   Lce1a2                                                                         −0.16/−0.3                                         −0.41/−0.52   −0.01/−0.18   −0.03/−0.2    −0.24/−0.37   −0.83/−0.86    −0.93/−0.94
   Nexn                                                                           −0.59/−0.47                                        −0.3/−0.08    −0.82/−0.76   −0.9/−0.87    −0.96/−0.95   −0.64/−0.52    −0.78/−0.71
   Pde4dip                                                                        −0.65/−0.69                                        −0.52/−0.58   −0.19/−0.29   −0.11/−0.22   −0.4/−0.47    −0.71/−0.75    −0.68/−0.72
   Plekho1                                                                        −0.07/−0.3                                         −0.8/−0.85    −0.8/−0.85    −0.85/−0.89   −0.97/−0.98   −0.95/−0.97    −0.98/−0.99
   Psrc1                                                                          −0.8/−0.7                                          −0.78/−0.67   −0.81/−0.73   −0.72/−0.59   −0.62/−0.45   −0.32/0        −0.38/−0.1
   Rhoc                                                                           −0.57/−0.52                                        −0.5/−0.43    −0.85/−0.83   −1/−1         −0.92/−0.91   −0.6/−0.55     −0.73/−0.69
   Rit1                                                                           −0.54/−0.53                                        −0.66/−0.65   −0.58/−0.57   −0.69/−0.68   −0.66/−0.65   −−0.25/−0.22   −0.57/−0.55
   Scamp3                                                                         −0.34/−0.34                                        −0.55/−0.55   −0.79/−0.79   −0.61/−0.61   −0.72/−0.72   −0.82/−0.82    −0.83/−0.83
   Sec22b                                                                         −0.41/−0.08                                        −0.5/−0.23    −0.49/−0.21   −0.55/−0.3    −0.63/−0.43   −0.56/−0.32    −0.65/−0.46
  \(B\) Genes up-regulated between 1-and 4-folds in TCs as compared with other                                                                                                                              
   Sh3glb1                                                                        −0.73/−0.68                                        −0.62/−0.54   −0.81/−0.77   −0.79/−0.75   −0.8/−0.76    −0.69/−0.62    −0.7/−0.63
   Tm4sf1                                                                         −1/−1                                              −0.6/−0.67    −0.85/−0.88   −1/−1         −1/−1         −0.99/−0.99    −0.99/−0.99
   Csf1                                                                           −0.71/−0.65                                        −0.73/−0.68   −0.93/−0.92   −0.98/−0.98   −0.98/−0.97   −0.91/−0.9     −0.92/−0.91

###### 

Summary of genes expressed preferentially in TCs, as compared with others

  Compared pairs/fold down-regulated                                                \>0                                                \>1          \>4                                                             
  --------------------------------------------------------------------------------- -------------------------------------------------- ------------ --------------- --------------- --------------- --------------- ---------------
  TC5 *versus* others                                                               79                                                 12           0                                                               
  TC10 *versus* others                                                              137                                                22           1                                                               
  TCs *versus* others                                                               59                                                 9            0                                                               
  Gene symbol                                                                       Folds (TC5 *versus* others/TC10 *versus* others)                                                                                
  Fibroblast                                                                        Stem                                               ATII         CD8_T\_BL       CD8_T\_LL       Basal_cell      Duct_cell       
  \(A\) Genes down-regulated between 0-and 1-folds in TCs as compared with others                                                                                                                                   
   1700027A23Rik                                                                    0.9/1.57                                           0.08/0.46    162.04/220.27   4.95/7.07       0.43/0.94       28.1/38.49      8.2/11.48
   2810403A07Rik                                                                    0.81/1.11                                          0.7/0.99     0.47/0.72       3.33/4.07       4.16/5.04       1.31/1.7        0.96/1.3
   4932438A13Rik                                                                    1.12/1.11                                          0.9/0.9      4.4/4.39        76.24/75.99     78.16/77.9      9.48/9.44       8.12/8.09
   4933421E11Rik                                                                    1.61/2.74                                          0.22/0.74    0.3/0.87        5.03/7.64       4.6/7.02        2.41/3.89       0.14/0.64
   A530020G20Rik                                                                    0.13/0.92                                          0.02/0.73    6.3/11.39       1.91/3.94       2.91/5.64       2.4/4.77        1.14/2.63
   Acadm                                                                            5.66/5.92                                          0.22/0.27    4.5/4.72        6.8/7.1         4.87/5.09       6.25/6.53       5.1/5.33
   Adh6a                                                                            0.46/0.67                                          0.44/0.65    5.68/6.63       8.32/9.65       11.57/13.37     50.97/58.39     25.27/29.03
   Ahcyl1                                                                           0.62/0.88                                          0.14/0.32    1.5/1.91        1.14/1.49       0.51/0.76       2.4/2.95        1.9/2.38
   Alx3                                                                             1.08/1.53                                          1.35/1.87    0.45/0.77       0.95/1.38       5.61/7.05       0.82/1.22       1.64/2.21
   Atp11b                                                                           0.44/0.93                                          0.99/1.66    2.2/3.29        28.57/38.63     22.24/30.15     10.08/13.85     15.11/20.59
   Car3                                                                             0.25/0.29                                          0.04/0.07    3.72/3.87       4.07/4.23       6.87/7.12       40.74/42.05     22.72/23.47
   Clcc1                                                                            1.62/2.56                                          0.03/0.39    0.08/0.47       0.81/1.45       0.7/1.31        3.29/4.83       3.25/4.77
   Cryz                                                                             3.65/6.13                                          3.67/6.15    0.91/1.92       0.17/0.79       0/0.53          0.51/1.32       2.14/3.8
   Ctso                                                                             0.22/0.15                                          1.18/1.05    151.36/142.4    336.91/317.03   271.25/255.24   245.94/231.42   92.66/87.15
   Gnat2                                                                            1.35/1.57                                          0.19/0.3     1.09/1.29       2.4/2.72        4.24/4.73       8.71/9.63       1.89/2.17
   Gpsm2                                                                            1.89/2.66                                          1.39/2.03    0.36/0.72       3.42/4.59       5.15/6.78       14.01/17.99     18.95/24.24
   Hax1                                                                             0.16/0.6                                           0.66/1.3     1.25/2.1        0.9/1.62        0.94/1.68       0.6/1.21        0.84/1.54
   Hltf                                                                             0.31/0.45                                          0.45/0.61    3.26/3.75       18.55/20.78     18.24/20.44     7.82/8.83       3.57/4.09
   Hps3                                                                             1.39/1.42                                          0.56/0.58    0.8/0.82        8.25/8.37       6.09/6.18       2.97/3.02       0.26/0.27
   Ints3                                                                            0.83/0.94                                          0.23/0.3     27.92/29.65     13.8/14.68      6.12/6.54       23.06/24.5      26.27/27.9
   Isg20l2                                                                          0.09/0.62                                          0.06/0.57    2.61/4.35       4.77/7.55       3.23/5.27       5.9/9.22        6.17/9.62
   Lass2                                                                            0.06/0.12                                          0.01/0.07    5.54/5.9        2.13/2.3        1.64/1.79       1.12/1.23       0.41/0.49
   Lrrc40                                                                           0.4/0.16                                           0.42/0.18    102.03/84.89    256.01/213.26   257.71/214.68   537.73/448.12   349.78/291.43
   Lrrcc1                                                                           0.1/0.63                                           0.19/0.77    0.6/1.37        2.23/3.8        1.26/2.35       5.2/8.21        2.45/4.13
   Mfsd8                                                                            0.71/0.3                                           0.45/0.11    11.71/8.67      24.91/18.72     19.66/14.72     32.59/24.56     33.42/25.19
   Mrpl24                                                                           0.64/1.57                                          0.06/0.66    1.1/2.27        3.11/5.41       1.92/3.56       1.85/3.45       1.82/3.41
   Mrpl9                                                                            0.29/0.47                                          0.44/0.64    3.16/3.73       7.18/8.3        5.33/6.19       8.23/9.48       7.87/9.08
   Ndufb5                                                                           1/1.86                                             0.01/0.44    2.17/3.55       2.34/3.79       0.88/1.69       2.78/4.42       2.95/4.66
   Odf2l                                                                            1.26/1.48                                          0.17/0.29    5.61/6.26       11.82/13.08     7.95/8.83       44.13/48.56     37.95/41.78
   Papss1                                                                           1.13/1.25                                          0.44/0.52    2.44/2.62       1.53/1.66       0.28/0.34       1.73/1.88       1.64/1.78
   Pgrmc2                                                                           1.11/1.55                                          0.08/0.31    4.75/5.96       1.45/1.97       2/2.62          29.73/36.17     15.37/18.8
   Plk4                                                                             0.46/0.88                                          0.71/1.2     2.33/3.29       11.64/15.29     12.8/16.79      7.3/9.69        12.53/16.43
   Prpf38b                                                                          1.18/0.93                                          0.68/0.49    11.25/9.81      50/44           66.2/58.3       44.75/39.37     34.78/30.58
   Rabggtb                                                                          0.81/0.52                                          1.09/0.75    8.12/6.64       53.93/45.01     57.59/48.07     37.82/31.52     48.92/40.81
   Rapgef2                                                                          0.29/0.68                                          0.63/1.11    2.8/3.92        10.47/13.85     8.15/10.86      0.24/0.6        0.61/1.09
   Rps4x                                                                            0.11/0.67                                          0.62/1.45    0.39/1.1        0.85/1.79       1.99/3.51       0.67/1.53       0.54/1.32
   Sars                                                                             3.16/4.85                                          1.32/2.27    1.03/1.86       0.4/0.98        0.09/0.54       0.41/0.99       0.3/0.83
   Setdb1                                                                           0.25/0.87                                          0.6/1.39     0.03/0.55       1.29/2.42       1.07/2.1        2.73/4.58       1.8/3.19
   Siah2                                                                            1.29/1.68                                          1.79/2.27    3.92/4.77       0.21/0.42       0.87/1.19       3.28/4.02       3.03/3.72
   Slc33a1                                                                          0.75/0.58                                          0.72/0.55    5.56/4.91       2.19/1.87       1.75/1.48       3.02/2.62       0.75/0.58
   Smc4                                                                             0.07/0.85                                          0.89/2.26    0.12/0.94       14.46/25.7      14.77/26.25     2.22/4.56       6.28/11.58
   Sohlh2                                                                           0.02/0.11                                          0.08/0.17    1.69/1.93       0.91/1.07       1.86/2.11       1.58/1.8        1.85/2.1
   Spata5                                                                           0.06/0.88                                          0.21/1.16    0.19/1.12       0.32/1.36       0.4/1.49        1.15/2.83       1.51/3.47
   Syt6                                                                             0.23/0.6                                           0.21/0.57    0.15/0.5        0.55/1.02       0.43/0.87       1.27/1.96       0.29/0.69
   Tbl1xr1                                                                          2.36/1.6                                           0.89/0.47    2.59/1.79       4.02/2.9        3.66/2.61       16.91/12.89     13.56/10.29
   Txnip                                                                            0.77/0.21                                          1.35/0.6     54.04/36.58     107.86/73.33    65.79/44.6      36.39/24.53     26.15/17.53
   Ubqln4                                                                           0.18/0.58                                          0.21/0.63    11.94/16.36     5.82/8.15       2.66/3.91       28.73/38.87     40.6/54.79
   Wdr77                                                                            0.14/0.7                                           0.97/1.92    3.67/5.93       1.52/2.74       0.79/1.66       2.28/3.88       2.96/4.88
   Ythdf3                                                                           0.22/0.54                                          0.64/1.07    3.08/4.17       6.8/8.87        6.44/8.41       3.68/4.92       3/4.06
   Zzz3                                                                             0.1/0.64                                           0.73/1.58    0.1/0.64        3.91/6.33       3.67/5.96       1.29/2.42       0.6/1.39
  \(B\) Genes down-regulated between 1-and 4-folds in TCs as compared with others                                                                                                                                   
   1700013F07Rik                                                                    6.5/7.08                                           1.64/1.84    34.73/37.52     2.1/2.34        7.8/8.48        29.96/32.38     47.84/51.65
   Amy1                                                                             2.81/3.86                                          8.06/10.55   9.44/12.32      7.37/9.67       14.79/19.13     31.07/39.88     24.64/31.68
   Anp32e                                                                           8.69/11.5                                          2.79/3.89    121.76/157.32   245.2/316.52    243.57/314.42   356.1/459.55    464.63/599.52
   Dnase2b                                                                          2.08/2.96                                          1.85/2.67    1.08/1.68       1.08/1.67       9.48/12.48      10.22/13.44     6.68/8.87
   Fmo5                                                                             3.8/6                                              3.36/5.35    3.52/5.58       4.08/6.4        1.75/3.01       21.33/31.55     5.4/8.33
   Pde5a                                                                            4.09/2.99                                          3.94/2.87    4.58/3.37       39.25/30.54     12.26/9.39      44.99/35.04     15.96/12.29
   Phf17                                                                            1.24/1.76                                          3.48/4.52    1.04/1.52       3.4/4.42        3.67/4.75       11.3/14.14      4.48/5.75
   Rwdd3                                                                            2.98/4.43                                          2.52/3.8     2.98/4.43       14.07/19.53     10.16/14.21     28.88/39.73     8.77/12.31
   Trim33                                                                           1.93/5.56                                          1.06/3.62    4.2/10.64       26.9/61.48      17.78/41.07     3.1/8.17        2.63/7.13

In chromosome 3 (Table[6](#tbl6){ref-type="table"}), up-or down-regulated genes more than 0-fold of TCs D5 were 345 or 222, 352 or 215, 377 or 190, 214 or 353, 201 or 366, 130 or 437, or 137 or 430, as compared with Fbs, MSCs, ATII, T-BL, T-L, ABCs or PACs respectively. Up-or down-regulated genes more than 0-fold of TCs D5 were 265 or 302, 263 or 304, 138 or 429, 188 or 379, 168 or 399, 95 or 472, or 120 or 447, as compared with Fbs, MSCs, ATII, T-BL, T-L, ABCs or PACs respectively. Up-and down-regulated genes more than 0-fold of TCs were 255 or 212, 247 or 199, 367 or 128, 181 or 346, 164 or 362, 87 or 429, or 110 or 420, as compared with Fbs, MSCs, ATII, T-BL, T-L, ABCs or PACs respectively. Details of up-or down gene variations of chromosome 2 and 3, including the number and names of up-or down-regulated genes more than 0-fold among different cells, were listed in Data S2.

###### 

The number of genes specifically up-or down-regulated in pulmonary telocytes, as compared with other cells respectively

  Compared pairs             Up\>0   Up\>1   Up\>4   Down\>0   Down\>1   Down\>4
  -------------------------- ------- ------- ------- --------- --------- ---------
  TC10 *versus* fibroblast   265     116     40      302       126       28
  TC5 *versus* fibroblast    345     161     51      222       87        17
  TCs *versus* fibroblast    255     100     33      212       78        12
  TC10 *versus* stem         263     109     35      304       115       23
  TC5 *versus* stem          352     134     41      215       63        12
  TCs *versus* stem          247     85      27      199       58        12
  TC10 *versus* ATII         138     67      22      429       306       177
  TC5 *versus* ATII          377     278     137     190       93        32
  TCs *versus* ATII          367     268     124     128       62        20
  TC10 *versus* CD8BL        188     117     59      379       302       186
  TC5 *versus* CD8BL         214     143     81      353       265       162
  TCs *versus* CD8BL         181     113     57      346       254       153
  TC10 *versus* CD8LL        168     99      51      399       307       197
  TC5 *versus* CD8LL         201     138     66      366       278       163
  TCs *versus* CD8LL         164     96      47      362       269       154
  TC10 *versus* basal cell   95      55      19      472       388       261
  TC5 *versus* basal cell    130     65      26      437       345       222
  TCs *versus* basal cell    87      45      16      429       339       218
  TC10 *versus* duct cell    120     56      26      447       373       234
  TC5 *versus* duct cell     137     81      29      430       321       199
  TCs *versus* duct cell     110     51      21      420       312       187

The relationships of the more than 0-fold up-regulated genes of chromosome 2 and 3 in TC D5 and/or TC D10 were analysed by String Network analysis ([www.string-db.org](http://www.string-db.org)), as compared with other cells, to identify direct (physical) and indirect (functional) associations between selected genes of TCs. TC-specific or dominating genes in TC D5 and TC D10 were selected by up-or down-expression more than 0-fold, as compared with other cells. Figure[1](#fig01){ref-type="fig"}A and C demonstrated the distribution of such active gene group in chromosome 2 and 3 of all cells, and interactions or potential functional links of those genes of TCs.

![Expression profiles of the selected genes as an active group of chromosome 2 and 3 of TCs (TCs) isolated and cultured from mouse lungs on days 5 (D5) and 10 (D10), as compared with fibroblasts (Fbs), mesenchymal stem cells (MSCs), alveolar type II cells (ATII), airway basal cells (ABCs), proximal airway cells (PACs), CD8+ T cells come from bronchial lymph nodes (T-BL), and CD8+ T cells from lung (T-L) respectively (**A** and **C**). The profiles for entire genes are described in Data S1. The selected core network and whole mouse network are linked by the documented functional interactions from various databases (see Methods). Genes in each network are indicated in red and some of their nearest neighbours are indicated by dark grey nodes. A group of telocyte genes up-regulated and down-regulated more than 0-fold as compared with all other cells and existed in TCs on days 5 and 10 were selected as telocyte-specific or dominated genes in chromosome 2 and 3 (**A** and **C**). Top 50 up-or down-regulated genes of each cells were also evaluated and their distribution within chromosome 2 and 3 genes showed the difference between cells (**B** and **D**). Details of the selected network in each cell type are in Figure S1--S18.](jcmm0018-2044-f1){#fig01}

In chromosome 2, about 30-50% of TCs genes showed similar patterns of gene expression in MSCs, Fbs or ATII, while 5-15% of TCs genes showed similarities with ABCs, PACs, T-BL or T-L. Top 50 up-or down-regulated genes of each cell were also evaluated and their distribution within chromosome 2 genes showed the difference between them, as shown in Figure[1](#fig01){ref-type="fig"}B. High expressed genes of each cell within chromosome 2 were evaluated and distributed as red colour (Fig.[1](#fig01){ref-type="fig"}B). The distribution of the high expressed genes and low expressed genes both in TC D5 and TC D10 indicates that they are in the centre of the small cluster and different from the other cells. Among the 26 co-up-expressed genes (Table[1](#tbl1){ref-type="table"}A--C), 7 genes were found to have certain interactions (Fig.[1](#fig01){ref-type="fig"}A).

In chromosome 3, about 50--60% of TCs genes showed similar patterns of gene expression in Fbs, MSCs, PACs or ABCs, while 0--20% of TCs genes showed similarities with ABCs, PACs, T-BL or T-L. Top 50 up-or down-regulated genes of each cell were also evaluated and their distribution within chromosome 3 genes showed the difference between them, as shown in Figure[1](#fig01){ref-type="fig"}D. High expressed genes of each cell within chromosome 3 were evaluated and distributed as red colour (Fig.[1](#fig01){ref-type="fig"}D). The distribution of up-expressed genes and down-expressed genes in TC D5 and TC D10 indicates that they are in the centre of the small cluster and different from the other cells. Among the 16 co-up-expressed genes (Table[4](#tbl4){ref-type="table"}A and B), no clear or certain interactions (Fig.[1](#fig01){ref-type="fig"}C) were found. The hierarchical cluster analysis of the differentially expressed genes ([Fig. 2](#fig02){ref-type="fig"}) clearly shows that TCs are poorly related to the other cell lines.

![Hierarchical cluster analysis of the differentially expressed genes on chromosomes 2 and 3 among telocytes (TCs), mesenchymal stem cells (MSCs), fibroblasts (Fbs), lymphocytes from lungs (T-LL) and from bronchial lymph nodes (T-BL), alveolar type II cells (ATII), proximal airway cells (PAC) and airway basal cells (ABC).](jcmm0018-2044-f2){#fig02}

Discussion
==========

Mouse chromosomes are the best studied mammalian chromosomes and are considered as gold standard of human comparative map, although genomic rearrangements occur during evolution. Certain human disease genes were discovered by comparative genomics using the information derived from mapped mouse mutations, although they are not the simplest model for human comparison. In humans, chromosome 2 has the largest sequenced base pairs (237, 712, 649) [@b47], working with all of the autosomes in humans, spanning the second largest amount of total base pairs (242, 751, 149) and representing 16.2% of the total DNA [@b48]--[@b51]. Over 31 exactly known diseases were proposed to be associated with genes on chromosome 2. In mouse, chromosome 2 is entirely sequenced and has 3146 genes encoding 1780 proteins [@b47], of which 917 genes were measured by bioinformatics tools in the present study. Our data demonstrated that there were 26 or 80 up-or down-regulated genes of chromosome 2 in TCs, as compared with MSCs, Fbs, ATII, T-BL, T-LL, ABCs or PACs.

One gene Myl9 (myosin, light polypeptide 9) was overexpressed most in TCs, different from other cells. Myl9 regulatory gene encodes the regulatory light chains of myosin II molecule, known to play a central role in cell adhesion, migration and division. Recent results showed Myl9 as the only gene differentially expressed in the aged *versus* young injured arteries [@b52] implying that it may be related to tissue/organ injury and ageing. Therefore, it is possible that the overexpression of Myl9 in pulmonary TCs may play an important role in lung injury and ageing. There were six genes, *e.g*. Pltp, Gzf1, Polr1b, Tasp1, Zbtb34 and Zfp120, down-expressed most in TCs, different from other cells. The Pltp (phospholipid transfer protein) gene is widely expressed in the body, and plays an important role in lipid metabolism, immune modulation, lipopolysaccharide binding or neurodegenerative disease [@b53]. Pltp is highly expressed within the lung epithelium, in chronic obstructive pulmonary disease or pulmonary inflammation [@b54]. TCs may play an important role of inhibiting inflammation in the lung. Roles of Gzf1 (GDNF-inducible zinc finger protein 1), Polr1b (polymerase (RNA) I polypeptide B), Tasp1 (taspase threonine aspartase 1), Zbtb34 (zinc finger and BTB domain containing 34) or Zfp120 (zinc finger protein 120) genes or proteins in the lung remain unclear. Thus, there is a further need to clarify the exact mechanisms and functions of these genes in TCs.

Mouse chromosome 3 has a total number of genes of 993 which encode a total of 669 proteins [@b47]. Human chromosome 3 has ∼7% of the human genome probably related with, at least, 121 diseases that are associated with 105 genes [@b55] and also spanning the third largest amount of total base pairs (199, 446, 827) and represented about 6.5% of the total DNA in cells [@b56]--[@b59]. The chromosome 3 has 1550 genes, of which 567 genes of chromosome 3 were measured by bioinformatics tools in the present study. We showed that there were 13 or 59 up-or down-regulated genes of chromosome 3 in TCs, as compared with Fbs, MSCs, ATII, T-BL, T-L, ABCs or PACs. There were three genes, *e.g*. Sh3glb1, Tm4sf1 and Csf1, overexpressed in TCs.

Sh3glb1 gene encodes SH3-domain GRB2-like B1 or endophilin, known to have an extremely close relationship with Bax-interacting factor-1 (bif-1) [@b60],[@b61], involved in cell survival and proliferation under metabolic stress and evasion of apoptosis. SH3glb1 is a membrane curvature-inducing protein interact with BECN1 though UVRAG and regulates the post-Golgi trafficking of membrane-integrated ATG9A for autophagy. At the premalignant stage, allelic loss of Sh3glb1 could enhance Myc-induced chromosomal instability and result in the up-regulation of anti-apoptotic proteins, including MCL1 and BCL2L1 [@b61], being responsible for enabling cells to survive and proliferate under metabolic stress and evasion of apoptosis. Endophilin is a membrane curvature-inducing protein that interacts with autophagy related beclin 1, although UV radiation resistance associated gene (Uvrag) and regulates the post-Golgi trafficking of membrane-integrated autophagy related 9A (Atg9A) protein. At the premalignant stage, allelic loss of Sh3glb1 enhances Myc-induced chromosomal instability and results in the up-regulation of anti-apoptotic proteins, including MCL1 and BCL2L1 [@b61]. So far, there is no reported association with any lung disease, however, we cannot exclude a role for TCs as having pro-proliferative effects through inhibition of apoptosis as showed in a previous study [@b41].

Tm4sf1 (transmembrane 4 superfamily member 1) is a distant member of the transmembrane 4 superfamily of cell-surface proteins characterized by the presence of four hydrophobic domains [@b62]. It is highly expressed in different carcinomas, *e.g*. in lung cancer [@b62], and lowly expressed in normal tissues [@b63]. Colony stimulating factor 1 (macrophage) (Csf1) plays an important role in cancer metastasis and invasion. It is highly expressed in different carcinomas and expressed at relatively low levels (if at all) in many normal tissues [@b63]. High expression of Csf1 can increase metastasis and invasion of pulmonary adenocarcinomas [@b64]. For example, Tm4sf1 it was up-regulated in human adenocarcinoma A549 cell line, suggesting a poor prognosis for anticancer therapy [@b65]. Overexpression of TM4SF1 and Csf1 in lung TCs may have a role in the development of lung cancer. Among down-expressed genes in TCs, Pde5a (cGMP-specific phosphodiesterase 5A) has an obvious association with acute and chronic interstitial lung disease. Overexpression of Pde5a may accelerate the formation of pulmonary fibrosis, while down-expression of Pde5a has important roles and effects in pulmonary fibrosis-associated pulmonary hypertension [@b66],[@b67]. Therefore, we concluded that Tm4sf1 and Csf1 found to be overexpressed in lung TCs may have a role in tumour promotion. There were nine genes, *e.g*. 1700013F07Rik, Amy1, Anp32e, Dnase2b, Fmo5, Pde5a, Phf17, Rwdd3 and Trim33, down-expressed most in TCs, different from other cells.

Among them, only phosphodiesterase 5a (Pde5a) cGMP-specific gene is obviously associated with acute and chronic interstitial lung disease. Its high expression promotes the pulmonary fibrosis, while the inhibition of Pde5a expression ameliorates right ventricular failure and pulmonary, when is associated with bleomicin, through a reduction in reactive oxygen species [@b68]. Therefore, Pde5a low expression in lung TCs may have therapeutic effect on pulmonary fibrosis and other acute and chronic interstitial lung disease, probably by modulation of oxidative stress levels, as previously shown [@b41].

In conclusion, the present study compared genetic variations of chromosome 2 and 3 of pulmonary TCs with other related cells, *e.g*. Fbs, MSCs, ATII, T-BL, T-L, ABCs or PACs. Our data showed a number of TCs-specific or dominant genes in chromosomes 2 and 3, different from other lung tissue resident cells or infiltrated cells. The TCs signatures of chromosome 2 and 3 genes indicate TCs may be mainly associated with anti-inflammatory responses, the prevention of lung cancer formation and development or protective effects on pulmonary fibrosis or acute and chronic interstitial lung diseases.
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